Abstract
Objective: The primary objective of this study was to determine whether early administration of intraperitoneal chemotherapy (IPC) and intraoperative insertion of an intraperitoneal (IP) port are associated with increased complications in patients who undergo a bowel resection procedure as part of primary cytoreductive surgery. Secondary outcomes included the impact of patient and surgical factors on progression-free survival (PFS) in this population, and measuring the association between the mode of delivery of chemotherapy and the time to chemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
